Diagnosis and treatment of primary XXXX of the parotid gland: a retrospective study - Experience at the Northern Israel Oncology Center (1977-1999).

@entity1893 @entity1 @entity244
PURPOSE: The treatment and outcome of primary @entity1893 ( @entity1893 ) has rarely been described. This retrospective study documents the clinicopathologic features and treatment results in this relatively rare entity. @entity1 AND METHODS: This study was conducted on 11 @entity1 diagnosed and treated for primary @entity1893 over a period of 22 years. RESULTS: Of the 4 male and 7 female @entity1 , only one presented with the classic pattern of Sj  @entity244 ( @entity244 ) simultaneous with @entity1893 , and only 4 @entity1 demonstrated a low-grade Maltoma type. None of the @entity1 had evidence of disease at the end of the primary treatment; 4 @entity1 are alive and well from 6 months to 10 years after the end of treatment. Four @entity1 relapsed and died due to therapy-resistant disease and 3 @entity1 died of nonmalignant causes while in complete remission. CONCLUSION: The majority of @entity1 with primary @entity1893 present with early- stage disease. Accurate staging is mandatory. Low-grade, localized @entity1893 can be treated successfully with primary radiotherapy alone. The aggressive type of @entity1893 should be treated with combined chemoradiotherapy-based regimens.
